China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Effect of Solvent Use During Root Canal Filling Removal on Post-Treatment Pain and Trea... Read More
China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Prevalence and Clinicopathological Features of the Estrogen Receptor 1Coiled-Coil Domai... Read More
China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Dual-Targeted Combined Intervention in High-Risk HBV-Related Hepatocellular Carcinoma: ... Read More
China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Early Cardiovascular Prediction Model and Management Strategies for Obesity and Precoci... Read More
China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Prospective, Multicenter, Randomized, Double-Blind, Sham-Controlled Study to Evaluate... Read More
China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Safety of Ultra-low-dose Radiotherapy Combined with Zuberitamab for Limite... Read More
China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Prospective, Multicenter, Randomized, Parallel-Controlled Superiority Study Evaluatin... Read More
China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The effect of obesity history on the efficacy of non-surgical periodontal treatment'. T... Read More
China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'To compare the efficacy and safety of generic sugammadex sodium injection and original ... Read More
China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A randomized double‑blind controlled trial of a dual orexin receptor antagonist for sle... Read More